Cargando…
Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
Amphotericin B (AmB) in its liposomal form is now considered as either first- or second-line treatment against Leishmania infections in different part of the world. Few cases of AmB resistance have been reported and resistance mechanisms toward AmB are still poorly understood. This paper reports a l...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095042/ https://www.ncbi.nlm.nih.gov/pubmed/25057462 http://dx.doi.org/10.1016/j.ijpddr.2014.05.002 |
_version_ | 1782325938404458496 |
---|---|
author | Brotherton, Marie-Christine Bourassa, Sylvie Légaré, Danielle Poirier, Guy G. Droit, Arnaud Ouellette, Marc |
author_facet | Brotherton, Marie-Christine Bourassa, Sylvie Légaré, Danielle Poirier, Guy G. Droit, Arnaud Ouellette, Marc |
author_sort | Brotherton, Marie-Christine |
collection | PubMed |
description | Amphotericin B (AmB) in its liposomal form is now considered as either first- or second-line treatment against Leishmania infections in different part of the world. Few cases of AmB resistance have been reported and resistance mechanisms toward AmB are still poorly understood. This paper reports a large-scale comparative proteomic study in the context of AmB resistance. Quantitative proteomics using stable isotope labeling of amino acids in cell culture (SILAC) was used to better characterize cytoplasmic and membrane-enriched (ME) proteomes of the in vitro generated Leishmania infantum AmB resistant mutant AmB1000.1. In total, 97 individual proteins were found as differentially expressed between the mutant and its parental sensitive strain (WT). More than half of these proteins were either metabolic enzymes or involved in transcription or translation processes. Key energetic pathways such as glycolysis and TCA cycle were up-regulated in the mutant. Interestingly, many proteins involved in reactive oxygen species (ROS) scavenging and heat-shock proteins were also up-regulated in the resistant mutant. This work provides a basis for further investigations to understand the roles of proteins differentially expressed in relation with AmB resistance. |
format | Online Article Text |
id | pubmed-4095042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-40950422014-07-23 Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum Brotherton, Marie-Christine Bourassa, Sylvie Légaré, Danielle Poirier, Guy G. Droit, Arnaud Ouellette, Marc Int J Parasitol Drugs Drug Resist Brief Report Amphotericin B (AmB) in its liposomal form is now considered as either first- or second-line treatment against Leishmania infections in different part of the world. Few cases of AmB resistance have been reported and resistance mechanisms toward AmB are still poorly understood. This paper reports a large-scale comparative proteomic study in the context of AmB resistance. Quantitative proteomics using stable isotope labeling of amino acids in cell culture (SILAC) was used to better characterize cytoplasmic and membrane-enriched (ME) proteomes of the in vitro generated Leishmania infantum AmB resistant mutant AmB1000.1. In total, 97 individual proteins were found as differentially expressed between the mutant and its parental sensitive strain (WT). More than half of these proteins were either metabolic enzymes or involved in transcription or translation processes. Key energetic pathways such as glycolysis and TCA cycle were up-regulated in the mutant. Interestingly, many proteins involved in reactive oxygen species (ROS) scavenging and heat-shock proteins were also up-regulated in the resistant mutant. This work provides a basis for further investigations to understand the roles of proteins differentially expressed in relation with AmB resistance. Elsevier 2014-05-16 /pmc/articles/PMC4095042/ /pubmed/25057462 http://dx.doi.org/10.1016/j.ijpddr.2014.05.002 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Brief Report Brotherton, Marie-Christine Bourassa, Sylvie Légaré, Danielle Poirier, Guy G. Droit, Arnaud Ouellette, Marc Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum |
title | Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum |
title_full | Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum |
title_fullStr | Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum |
title_full_unstemmed | Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum |
title_short | Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum |
title_sort | quantitative proteomic analysis of amphotericin b resistance in leishmania infantum |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095042/ https://www.ncbi.nlm.nih.gov/pubmed/25057462 http://dx.doi.org/10.1016/j.ijpddr.2014.05.002 |
work_keys_str_mv | AT brothertonmariechristine quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum AT bourassasylvie quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum AT legaredanielle quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum AT poirierguyg quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum AT droitarnaud quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum AT ouellettemarc quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum |